Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Neoplasm Metastasis × Trabectedin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 7 Leiomyosarcoma 3 Sarcoma, Synovial 2 Sarcoma, Alveolar Soft Part 2 Neurofibrosarcoma 2 Malignant mesenchymal tumor 2 Liposarcoma 2 Histiocytoma, Malignant Fibrous 2 Hemangiosarcoma 2 Hemangiopericytoma, Malignant 2 Fibrosarcoma 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Solitary Fibrous Tumors 1 Soft Tissue Neoplasms 1 Sarcoma, Ewing 1 Sarcoma, Endometrial Stromal 1 Rhabdomyosarcoma 1 Recurrent High Grade Meningioma 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Ichthyosis, X-Linked 1 Gastrointestinal Stromal Tumors 1 Endometrial Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Chondrosarcoma, Extraskeletal Myxoid 1 Central Nervous System Neoplasms 1 Bone Neoplasms 1

Interventions

Radiotherapy 9 Radiosurgery 6 Oxaliplatin 5 Cisplatin 5 Paclitaxel 4 Capecitabine 4 Leucovorin 3 Fluorouracil 3 Doxorubicin 3 Docetaxel 3 regorafenib 2 pembrolizumab 2 enzalutamide 2 Temozolomide 2 Radiofrequency Ablation 2 Mitomycin 2 Irinotecan 2 Ifosfamide 2 Gemcitabine 2 Filgrastim 2 Bleomycin 2 Bevacizumab 2 Analgesia 2 Albumin-Bound Paclitaxel 2 trifluridine tipiracil drug combination 1 spartalizumab 1 sargramostim 1 plozalizumab 1 palbociclib 1 orteronel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02066675 2018-04-11

TR1US

Italian Sarcoma Group

Phase 2 Completed

Neoplasm Metastasis, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡